Johnson & Johnson’s Illumina ILMN Stock Holding History

Johnson & Johnson’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-832,855	Closed	-$329M	–	25
2021 Q3	$329M	Buy	+832,855	New	+$383M	28.83%	1

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Johnson & Johnson's ILMN Position: Q4 2021 in Review

Johnson & Johnson sold out of Illumina (ILMN) in Q4 2021, closing a stake of 832,855 shares — an estimated $329M sold.

Johnson & Johnson first reported a position in ILMN in Q3 2021 and held it in 1 quarter. The position peaked at $329M in Q3 2021. 1,066 funds tracked by Wall St. Rank hold ILMN as of Q4 2021.

Johnson & Johnson reported no remaining Illumina position as of Q4 2021 after selling out during the quarter.
Johnson & Johnson sold 832,855 Illumina shares in Q4 2021, an estimated $329M.
Johnson & Johnson first reported a position in Illumina in Q3 2021 and held it in 1 quarter.
Johnson & Johnson's Illumina position peaked at $329M in Q3 2021.
1,066 funds tracked by Wall St. Rank held Illumina as of Q4 2021.

Based on Johnson & Johnson's 13F filing for Q4 2021, filed 14 Feb 2022.